title: Heart transplantation an answer for end-stage heart failure.
abstract: Heart transplantation remains the best treatment option for end-stage heart failure. For patients who are not candidates for transplantation, better medical management and surgical options in heart failure can improve both the length and quality of a patient's life. Continuing research on xenotransplantation and the total artificial heart may decrease the need for human transplantation in years to come and may allow others with severe heart failure to have a chance at living longer.
authors.affiliation: Medical University of South Carolina, 171 Astley Avenue, Charleston, SC 29425, USA. smithla@musc.edu
authors.forename: Lanna
authors.initials: L
authors.lastname: Smith
authors.forename: Jennifer
authors.initials: J
authors.lastname: Farroni
authors.forename: Barbara Ryan
authors.initials: BR
authors.lastname: Baillie
authors.forename: Hwajoo
authors.initials: H
authors.lastname: Haynes
mesh_terms: D000075202:Contraindications; D005544:Forecasting; D006333:Heart Failure / Q000453:epidemiology / Q000601:surgery*; D016027:Heart Transplantation / Q000379:methods / Q000639:trends; D006353:Heart-Assist Devices; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D018579:Patient Selection; D011300:Preoperative Care / Q000379:methods; D011379:Prognosis; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D014850:Waiting Lists